← All Fibrobiologics, INC filings

Fibrobiologics, INC Form 4 insider transactions

NASDAQ
FBLG
Fibrobiologics, INC
Form 4: FibroBiologics Chief Scientific Officer Hamid Khoja Reports Stock Transaction
Hamid Khoja, Chief Scientific Officer of FibroBiologics, Inc. (FBLG), reported the acquisition and disposal of common stock on August 12, 2024.
NASDAQ
FBLG
Fibrobiologics, INC
Form 4: FibroBiologics General Counsel Ruben A. Garcia Granted Stock Options
Ruben A. Garcia, General Counsel of FibroBiologics, Inc., was granted options to purchase 180,000 shares of common stock on March 1, 2024.